Global Viral Molecular Diagnostics Market

Viral Molecular Diagnostics Comprehensive Study by Type (Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)), Application (Infectious Diseases, Genetics, Blood Screening, Microbiology, Others), End-users (Hospitals, Academics Institutions, Laboratories, Others), Technology Type (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, In Situ Hybridization, DNA Sequencing, Next-Generation Sequencing, Other) Players and Region - Global Market Outlook to 2027

Viral Molecular Diagnostics Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Viral Molecular Diagnostics?
Viral molecular diagnostics are the processes used to analyze how individual’s cells express their genes as protein. There are various molecular techniques such as met-generation sequencing, DNA sequencing, Polymerase Chain Reaction (PCR) microarrays, and others. These techniques are used to analyze and monitor various diseases, risk associated with diseases, and others factors in order to determine which therapies would work better.

The market study is broken down by Type (Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV) and Human Papillomavirus (HPV)), by Application (Infectious Diseases, Genetics, Blood Screening, Microbiology and Others) and major geographies with country level break-up. and may see market size of USD17.6 Billion by 2027.

Analysts at AMA Research estimates that Players from American will contribute to the maximum growth of Global Viral Molecular Diagnostics market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboraories (United States), Bio-Rad Laboratories (United States), Becton Dickinson (United States), Roche Holding AG (Switzerland), Gen-Probe (United States), Qiagen (Germany), Olympus (Japan) and Thermo Fisher Scientific (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Affymetrix, Inc. (United States), Auto Genomics Inc (United States), Beckman Coulter (United States), BioMérieux SA (France), Meridian Bioscience, Inc (United States) and Sanofi (France).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Viral Molecular Diagnostics market by Type, Application and Region.

On the basis of geography, the market of Viral Molecular Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2021. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Viral Molecular Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology Type, the sub-segment i.e. Polymerase Chain Reaction (PCR) will boost the Viral Molecular Diagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Growing Use of Viral Molecular Diagnostics in Detection of target
  • Genes of Interest

Market Drivers
  • Rise in Demand for Advanced Molecular Tests
  • Growing Outbreak of Viral Infection Diseases

Opportunities
  • Technological Advancement in Molecular Diagnostics
  • Development of Low-cost Viral Molecular Diagnostics Techniques

Restraints
  • High Cost of Viral Molecular Diagnostics
  • Lack of Skilled Personnel to Diagnose Viral Molecular

Challenges
  • Advent of Cost-effective Alternative Microfluidic Technology


Key Target Audience
Viral Molecular Diagnostics Service Providers, End-user Industries, Market Research and Consulting Firms, Government Bodies and Research Institutes, Potential Investors and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Hepatitis B Virus (HBV)
  • Hepatitis C Virus (HCV)
  • Human Immunodeficiency Virus (HIV)
  • Human Papillomavirus (HPV)
By Application
  • Infectious Diseases
  • Genetics
  • Blood Screening
  • Microbiology
  • Others
By End-users
  • Hospitals
  • Academics Institutions
  • Laboratories
  • Others

By Technology Type
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microarrays
  • In Situ Hybridization
  • DNA Sequencing
  • Next-Generation Sequencing
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Demand for Advanced Molecular Tests
      • 3.2.2. Growing Outbreak of Viral Infection Diseases
    • 3.3. Market Challenges
      • 3.3.1. Advent of Cost-effective Alternative Microfluidic Technology
    • 3.4. Market Trends
      • 3.4.1. Growing Use of Viral Molecular Diagnostics in Detection of target
      • 3.4.2. Genes of Interest
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Viral Molecular Diagnostics, by Type, Application, End-users, Technology Type and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Viral Molecular Diagnostics (Price)
      • 5.2.1. Global Viral Molecular Diagnostics by: Type (Price)
  • 6. Viral Molecular Diagnostics: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Abbott Laboraories (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Bio-Rad Laboratories (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Becton Dickinson (United States)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Roche Holding AG (Switzerland)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Gen-Probe (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Qiagen (Germany)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Olympus (Japan)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Thermo Fisher Scientific (United States)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
  • 7. Global Viral Molecular Diagnostics Sale, by Type, Application, End-users, Technology Type and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Viral Molecular Diagnostics (Price)
      • 7.2.1. Global Viral Molecular Diagnostics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Viral Molecular Diagnostics: by Type(USD/Units)
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Viral Molecular Diagnostics: by Type(USD/Units)
  • Table 11. Research Programs/Design for This Report
  • Table 12. Key Data Information from Secondary Sources
  • Table 13. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Viral Molecular Diagnostics: by Type USD/Units (2016-2021)
  • Figure 5. Abbott Laboraories (United States) Revenue, Net Income and Gross profit
  • Figure 6. Abbott Laboraories (United States) Revenue: by Geography 2021
  • Figure 7. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 8. Bio-Rad Laboratories (United States) Revenue: by Geography 2021
  • Figure 9. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 10. Becton Dickinson (United States) Revenue: by Geography 2021
  • Figure 11. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 12. Roche Holding AG (Switzerland) Revenue: by Geography 2021
  • Figure 13. Gen-Probe (United States) Revenue, Net Income and Gross profit
  • Figure 14. Gen-Probe (United States) Revenue: by Geography 2021
  • Figure 15. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 16. Qiagen (Germany) Revenue: by Geography 2021
  • Figure 17. Olympus (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Olympus (Japan) Revenue: by Geography 2021
  • Figure 19. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific (United States) Revenue: by Geography 2021
  • Figure 21. Global Viral Molecular Diagnostics: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Abbott Laboraories (United States)
  • Bio-Rad Laboratories (United States)
  • Becton Dickinson (United States)
  • Roche Holding AG (Switzerland)
  • Gen-Probe (United States)
  • Qiagen (Germany)
  • Olympus (Japan)
  • Thermo Fisher Scientific (United States)
Additional players considered in the study are as follows:
Affymetrix, Inc. (United States) , Auto Genomics Inc (United States) , Beckman Coulter (United States) , BioMérieux SA (France) , Meridian Bioscience, Inc (United States) , Sanofi (France)
Select User Access Type

Key Highlights of Report


Jan 2022 238 Pages 81 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Viral Molecular Diagnostics Market Quantitative research analysis
Global Viral Molecular Diagnostics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Laboraories (United States), Bio-Rad Laboratories (United States), Becton Dickinson (United States), Roche Holding AG (Switzerland), Gen-Probe (United States), Qiagen (Germany), Olympus (Japan) and Thermo Fisher Scientific (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Viral Molecular Diagnostics Market to reach USD17.6 Billion by 2027.

Know More About Global Viral Molecular Diagnostics Market Report?

Have a Query? Click Here

Other Related Reports

Simple Island Dressings Comprehensive Study by Type (Traditional Wound Dressings, Advanced Wound Dressings), Application (Wet Wound, Dry Wound), Distribution Channel (Online, Offline), Size (2"x2" (...
$ 3450
Teicoplanin Comprehensive Study by Type (200 mg, 400 mg), Application (Bone and Joint Infection, Severe Skin and Soft Tissue Infection, Bacteraemia, Others), End-User (Adults, Children) Players and R...
$ 3500
Protein A Resin Comprehensive Study by Type (Natural Protein A, Recombinant Protein A), Application (Immunoprecipitation, Antibody Purification), Matrix (Glass or Silica Gel-based Matrix, Agarose-bas...
$ 3450
Sage Herbs Comprehensive Study by Application (Food and Beverage, Dietary Supplements, Personal Care and Cosmetics, Others), Category (Organic Sage Herb, Conventional Sage Herb), Form (Powder Form, L...
$ 3800
Seborrheic Dermatitis Treatment Comprehensive Study by Type (Antifungal Products, Corticosteroid Lotions, Prescription-Strength Medicated Shampoos, Sulfur Products), Route of Administration (Oral, To...
$ 3650
Digestion Aids Comprehensive Study by Type (Probiotics, Digestive Enzymes, Fiber Supplements), Application (Food and Beverages, Supplements), Distribution Channel (Direct Sale (Offline, Online), Dis...
$ 3750